SERNOVA Forum: Community User: COLOGNE79

Eine Wahnsinns Meldung! Trotzdem stelle ich mich auf mich so einige auf und abs ein, bevor es hier richtig los geht.

Hier auf deutsch: https://m.onvista.de/news/irw-news-sernova-corp-sernova-erreicht-im-rahmen-der-klinischen-phase-i-ii-studie-zur-typ-1-diabetes-positiven-wirksamkeitsendpunkt-328174035

LONDON, ONTARIO – February 13, 2020 – Sernova Corp (TSX-V:SVA)(OTCQB:SEOVF)(FSE:PSH), a clinical- stage company and regenerative medicine therapeutics leader, is pleased to announce that Sernova’s first treated patient in its Phase I/II clinical trial of its Cell Pouch with therapeutic cells for type 1 diabetes at the University of Chicago, has demonstrated survival of endocrine tissue (insulin-producing islets) in the sentinel Cell Pouch following 90 days transplant. This efficacy outcome, namely, survival of endocrine tissue (insulin-producing islets) in the sentinel Cell Pouch following 90 days transplant, is measured by positive staining of islets during histological analysis. According to the independent pathologist who conducted the analysis, “The explanted sentinel pouch shows abundant viable, organized islet cells intimately associated with blood vessels within a collagen matrix after 90 days of transplantation. These surviving islet cells strongly express insulin.” A representative histological image from the islet-transplanted mini-sentinel Cell Pouch explanted from a patient at 90 days post-transplant. Islets with positive insulin staining (red), and new blood vessels (green) are detected. (A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation.) This achievement is important because it is an indicator of transplanted islet health in the therapeutic Cell Pouches remaining in the subject, including the islets ability to produce insulin into the bloodstream. This has been demonstrated by our previous reported findings of blood levels of both glucose-stimulated and fasting C- peptide as well as other efficacy indicators in this patient who had no measurable levels of this biomarker of insulin prior to the Cell Pouch islet transplant. “We believe these accumulating positive results continue to validate our Cell Pouch technologies as a viable regenerative medicine therapeutic platform for humans in insulin-dependent diabetes and other chronic diseases,” said Dr. Philip Toleikis, President and CEO of Sernova Corp. “With these encouraging results and the positive review and recommendation from the Data Safety and Monitoring Board (DSMB), we are excited to continue the clinical trial and carry on compiling safety and efficacy data from our current and future treated patients.”

Hoffentlich nachhaltig, lassen wir uns mal überraschen.

Bzw. heute 😄

Dafür knallt Sernova dann umso mehr 😃🚀

Das mich der Mist hier langsam nervt😅 andere Biotechs die noch in den Studien performen wie S** und Sernova kommt nicht aus den Puschn. Naja, abwarten.

Das heißt? 🧐

Sell the News halt

https://www.sernova.com/press/release/?id=269&utm_source=Sernova Press Releases&utm_campaign=20bda84f45-EMAIL_CAMPAIGN_2020_02_10_12_55&utm_medium=email&utm_term=0_9ed1d79ce4-20bda84f45-354323691

Das war so klar😫

Die 2,7Mio am 07.02. waren übrigens der zweitgrößte Block der jemals gehandelt wurde. Nur vor fast genau einem Jahr am 14.02. wurden knapp 5 Mio in einem Block gehandelt. Quelle tmxmatrix.com

Bin gespannt wie es am Montag weiter geht. Wieder nur ein Strohfeuer oder diesmal vielleicht doch fundierte Nachhaltigkeit? Irgendwann muss es doch mal anziehen.

Marktplätze

Wo sieht man das? Wieviele Aktien schon gehandelt wurden?

Schon 3,4 mille